rotigotine (Kolster Methods)
90
Structured Review
Kolster Methods
rotigotine
Rotigotine, supplied by Kolster Methods, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rotigotine/rotigotine/pmc11956487-274-12-19
Average 90 stars, based on 1 article reviews
Rotigotine, supplied by Kolster Methods, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/rotigotine/rotigotine/pmc11956487-274-12-19
Average 90 stars, based on 1 article reviews
rotigotine - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data"
Article Title: Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data
Journal: BMC Pharmacology & Toxicology
doi: 10.1186/s40360-025-00911-5
Figure Legend Snippet: The flow diagram of selecting Rotigotine-related AEs from FAERS database
Techniques Used:
Figure Legend Snippet: Clinical characteristics of reports with rotigotine from the FAERS database
Techniques Used:
Figure Legend Snippet: Time to onset of Rotigotine-associated adverse events and Weibull distribution analysis
Techniques Used:
Figure Legend Snippet: The signal strength of AEs related to rotigotine at the SOC level in the FAERS database was detected by four algorithms
Techniques Used:
Figure Legend Snippet: Signal Strength of top20 AEs of Rotigotine at the PT Level in FAERS Database
Techniques Used:
Figure Legend Snippet: The top 30 most frequent adverse events for rotigotine excluding common medication co-usage at the PT level from FAERS data
Techniques Used:
Figure Legend Snippet: The top 30 signal strength of adverse events of rotigotine ranked by the number of case reports at the PTs level in FAERS database
Techniques Used:
Related Articles
other:Article Title: Dopaminergic Therapy for Restless Legs Syndrome/Willis-Ekbom Disease. Article Snippet: Several dopamine agonists are approved for the treatment of restless legs syndrome (RLS)/WillisEkbom disease (WED).. Although they have similar profiles, there are specific instances that may favor one more than another.. Sinemet can be used for short-term intermittent circumstances of forced immobilization, such as airplane flights. Article Title: Rotigotine safety in real-world settings: a pharmacovigilance study using FAERS data Article Snippet: Concurrently, in a German clinical trial assessing the efficacy and tolerability of rotigotine for treating RLS led by Karin Article Title: Rotigotine in the treatment of primary restless legs syndrome: A meta-analysis of randomized placebo-controlled trials. Article Snippet: Jun DING (丁 君), Wei FAN (范 威), Hong-hui CHEN (陈红辉), Peng YAN (闫 鹏) , Sheng-gang SUN (孙圣刚), Jin ZHENG (郑 瑾) Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China Department of Breast Surgery, Hubei Cancer Hospital, Wuhan 430079, China Wuhan First Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China Article Title: Rotigotine transdermal patch in the treatment of Parkinson's disease and restless legs syndrome. Article Snippet: Dopamine agonists are effective in delaying levodopa-induced dyskinesia in early Parkinson’s disease (PD) and reducing motor fluctuations in advanced PD.. Rotigotine, a novel dopamine receptor agonist, improves motor function in both early and advanced PD using a transdermal route of administration.. A smaller, but convincing body of data, supports its ability to ameliorate the symptoms of restless legs syndrome as well. Article Title: Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome. Article Snippet: In 684 patients with moderate-to-severe Article Title: Dopamine agonists for the treatment of restless legs syndrome Article Snippet: [ Google Scholar ] Stiasny‐Kolster 2004b {published and unpublished data} Clinical Proteomics:Article Title: Patch application of the dopamine agonist rotigotine to patients with moderate to advanced stages of restless legs syndrome: a double-blind, placebo-controlled pilot study. Article Snippet: Efficacy and safety of the dopamine agonist rotigotine (RTG) was investigated in patients with moderate to severe idiopathic restless legs syndrome (RLS), including daytime symptoms.. Three fixed doses of rotigotine (1.125 mg, 2.25 mg, and 4.5 mg) and placebo were applied by patches (size, 2.5 cm per 1.125 mg) in a double-blind, randomized, parallel-group, multicenter, 1-week, proof-ofprinciple trial.. The primary efficacy measure was the total score on the International Restless Legs Syndrome Scale (IRLS). Article Title: The use of rotigotine in the treatment of restless legs syndrome Article Snippet: .. Clinical trials The efficacy of |
